Sustained Acoustic Medicine for Osteoarthritis Pain
ZetrOZ, Inc.
Summary
The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
Eligibility
- Age range
- 35–85 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Have physician-diagnosed mild to moderate knee, shoulder, elbow, ankle, hip, or spine osteoarthritis OA (OARSI atlas grades 1-2) or also referred to as Degenerative Joint Disease (DJD). * Fulfill the American College of Rheumatology clinical and radiological diagnostic criteria for knee OA * Are between 35-85 years of age * Report a frequent pain score between 3-7 (range: 0-10) during the week preceding enrollment * Report that knee, shoulder, elbow, ankle, hip, or spine pain negatively affects quality of life * Are willing not to use any cream, gel, or topical solution…
Interventions
- DeviceSustained Acoustic Device with 2.5% Diclofenac Patch
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm@ with 2.5% Diclofenac patches.
- Drug2.5% Diclofenac Patches
Topical pain relief-gel worn for 4 hours at least 5 days a week via SAM patch.
Location
- James A Haley Veterans HospitalTampa, Florida